UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

The lancet oncology, 2019-04, Vol.20 (4), p.518-530

2019

Volltextzugriff (PDF)

Nanomedicine in cancer therapy: Innovative trends and prospects

Cancer science, 2011-07, Vol.102 (7), p.1247-1252

2011

Volltextzugriff (PDF)

Targeting the PI3K pathway in cancer: are we making headway?

Nature reviews. Clinical oncology, 2018-05, Vol.15 (5), p.273-291

2018

Volltextzugriff (PDF)

Biliary cancer: Utility of next‐generation sequencing for clinical management

Cancer, 2016-12, Vol.122 (24), p.3838-3847

2016

Volltextzugriff (PDF)

Clinical and molecular characterization of early‐onset colorectal cancer

Cancer, 2019-06, Vol.125 (12), p.2002-2010

2019

Volltextzugriff (PDF)

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes

Clinical cancer research, 2018-03, Vol.24 (5), p.1062-1072

2018

Volltextzugriff (PDF)

State-of-the-Art Strategies for Targeting RET -Dependent Cancers

Journal of clinical oncology, 2020-04, Vol.38 (11), p.1209-1221

2020

Volltextzugriff (PDF)

The immunogenomic landscape of resected intrahepatic cholangiocarcinoma

Hepatology (Baltimore, Md.), 2022-02, Vol.75 (2), p.297-308

2022

Volltextzugriff (PDF)

Targeting the mTOR Signaling Network for Cancer Therapy

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2278-2287

2009

Volltextzugriff (PDF)

Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer

International journal of cancer, 2020-07, Vol.147 (2), p.413-422

2020

Volltextzugriff (PDF)

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

Cancer, 2023-09, Vol.129 (17), p.2685-2693

2023

Volltextzugriff (PDF)

Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials

The oncologist (Dayton, Ohio), 2021-07, Vol.26 (7), p.588-596

2021

Volltextzugriff (PDF)

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Journal of clinical oncology, 2018-02, Vol.36 (6), p.536-542

2018

Volltextzugriff (PDF)

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical oncology clinics of North America, 2013-10, Vol.22 (4), p.641-664

2013

Volltextzugriff (PDF)

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing

Cell, 2018-01, Vol.172 (1-2), p.205-217.e12

2018

Volltextzugriff (PDF)

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1300-1309

2018

Volltextzugriff (PDF)

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Cancer, 2024-02, Vol.130 (3), p.400-409

2024

Volltextzugriff (PDF)

Associations between the gut microbiome and fatigue in cancer patients

Scientific reports, 2021-03, Vol.11 (1), p.5847-5847, Article 5847

2021

Volltextzugriff (PDF)

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

Molecular cancer therapeutics, 2018-07, Vol.17 (7), p.1595-1601

2018

Volltextzugriff (PDF)

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

The lancet oncology, 2021-09, Vol.22 (9), p.1290-1300

2021

Volltextzugriff (PDF)

Precision Oncology Decision Support: Current Approaches and Strategies for the Future

Clinical cancer research, 2018-06, Vol.24 (12), p.2719-2731

2018

Volltextzugriff (PDF)

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Clinical cancer research, 2019-04, Vol.25 (7), p.2033-2041

2019

Volltextzugriff (PDF)

Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified

Cancer, 2022-02, Vol.128 (3), p.509-518

2022

Volltextzugriff (PDF)

Clonal evolution in breast cancer revealed by single nucleus genome sequencing

Nature (London), 2014-08, Vol.512 (7513), p.155-160

2014

Volltextzugriff (PDF)

1 – 25 von 1.257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.175)
Mit Volltextzugriff
(1.120)

Publikationsform

Sprache

Englisch
(1.257)
Japanisch
(6)
Türkisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(270)
Cancer Research
(169)
Cancer
(82)
Clinical Cancer Research
(79)
Annals Of Surgical Oncology
(54)
Molecular Cancer Therapeutics
(46)
Oncotarget
(35)
Jco Precision Oncology
(24)
Journal For Immunotherapy Of Cancer
(18)
Cancer Discovery
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Nanomedicine in cancer therapy: Innovative trends and prospects

Targeting the PI3K pathway in cancer: are we making headway?

Biliary cancer: Utility of next‐generation sequencing for clinical management

Clinical and molecular characterization of early‐onset colorectal cancer

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes

State-of-the-Art Strategies for Targeting RET -Dependent Cancers

The immunogenomic landscape of resected intrahepatic cholangiocarcinoma

Targeting the mTOR Signaling Network for Cancer Therapy

Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

Patient‐Reported Out‐of‐Pocket Costs and Financial Toxicity During Early‐Phase Oncology Clinical Trials

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Associations between the gut microbiome and fatigue in cancer patients

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer

Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study

Precision Oncology Decision Support: Current Approaches and Strategies for the Future

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified

Clonal evolution in breast cancer revealed by single nucleus genome sequencing

Suchergebnisse filtern